← All companies
Roivant Sciences Ltd.
ROIV - CIK 0001635088
Market cap$21.12 B
Rank#603
SEC filings868
The table below shows Roivant Sciences Ltd.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.48B | $1.24B | $1.24B | $1.99B | $1.96B | $5.68B |
| Short-term investments | $3.05B | $3.15B | $3.26B | $3.16B | $3.43B | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | $34.00M |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.